Earnings History Data for Arcutis Biotherapeutics, Inc. (ARQT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics Inc. is late-stage biopharmaceutical company. It is focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases. The company's product pipeline consists of ARQ-151, ARQ-154 and ARQ-252 for multiple indications, including psoriasis, atopic dermatitis, seborrheic dermatitis and eczema, which are in clinical stage. Arcutis Biotherapeutics Inc. is based in Westlake Village, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
28-10-2025	PM		ARQT	Arcutis Biotherapeutics, Inc.	2,410	0.06	-0.09	-0.33	Arcutis Biotherapeutics GAAP EPS of $0.06 beats by $0.16, revenue of $99.2M beats by $12.22M [10/28/2025 9:07 AM]	24.99	5.35 (27.24%)	22.50	2.86 (14.56%)	8.21 - 25.75	11,061,507	1,420,000	174,073
Arcutis Biotherapeutics GAAP EPS of $0.06 beats by $0.16, revenue of $99.2M beats by $12.22M [10/28/2025 9:07 AM] What To Expect From Arcutis Biotherapeutics Inc (ARQT) Q3 2025 Earnings [Oct-27-25 09:30AM]
06-08-2025	AH		ARQT	Arcutis Biotherapeutics, Inc.	1,730	-0.13	-0.17	-0.42	Arcutis Biotherapeutics GAAP EPS of -$0.13 beats by $0.02, revenue of $81.5M beats by $7.83M [8/6/2025 4:03 PM]	14.11	-1.25 (-8.17%)	16.20	0.84 (5.47%)	8.03 - 17.75	4,066,488	1,490,000	25,517
Arcutis Biotherapeutics GAAP EPS of -$0.13 beats by $0.02, revenue of $81.5M beats by $7.83M [8/6/2025 4:03 PM] Arcutis outlines sustained ZORYVE growth with 28% sequential revenue expansion and eyes cash flow breakeven in 2026 [8/7/2025 2:54 AM] Arcutis Biotherapeutics Inc (ARQT) Q2 2025: Everything You Need to Know Ahead of Earnings [Aug-05-25 09:49AM]
06-05-2025	AH		ARQT	Arcutis Biotherapeutics, Inc.	1,810	-0.20	-0.21	-0.32	Arcutis Biotherapeutics GAAP EPS of -$0.20 beats by $0.02, revenue of $65.8M beats by $3.32M [5/6/2025 4:23 PM]	13.66	-0.66 (-4.61%)	14.19	-0.13 (-0.91%)	6.99 - 17.75	4,116,861	0	30,706
Arcutis Biotherapeutics GAAP EPS of -$0.20 beats by $0.02, revenue of $65.8M beats by $3.32M [5/6/2025 4:23 PM] Arcutis outlines growth potential with ZORYVE expansions and market penetration [5/6/2025 11:01 PM] What To Expect From Arcutis Biotherapeutics Inc (ARQT) Q1 2025 Earnings [May-05-25 09:43AM] Arcutis Announces First Quarter 2025 Financial Results and Provides Business Update [2025-05-06 04:00PM] Arcutis Biotherapeutics, Inc. (ARQT) Reports Q1 Loss, Tops Revenue Estimates [2025-05-06 05:10PM]
25-02-2025	AH		ARQT	Arcutis Biotherapeutics, Inc.	1,520	-0.09	-0.27	-0.72	Arcutis Biotherapeutics GAAP EPS of -$0.09 beats by $0.15, revenue of $71.3M beats by $10.78M [2/25/2025 4:09 PM]	13.12	0.92 (7.54%)	13.52	1.32 (10.82%)	6.99 - 16.20	3,420,754	2,740,000	33,549
Arcutis Biotherapeutics GAAP EPS of -$0.09 beats by $0.15, revenue of $71.3M beats by $10.78M [2/25/2025 4:09 PM] Arcutis rises as lead product undergoes FDA review for label expansion [2/26/2025 9:08 AM] Arcutis Biotherapeutics Inc (ARQT) Q4 2024: Everything You Need To Know Ahead Of Earnings [2025-02-25 01:33AM] Arcutis Announces Publication of Positive Data from INTEGUMENT-PED Trial Evaluating ZORYVE (roflumilast) Cream 0.05% in Children 2 to 5 Years Old with Mild to Moderate Atopic Dermatitis in Pediatric Dermatology [Feb-24-25 08:00AM] Arcutis Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update [2025-02-25 04:00PM] Arcutis Biotherapeutics, Inc. (ARQT) Reports Q4 Loss, Tops Revenue Estimates [2025-02-25 05:10PM] Arcutis Biotherapeutics Inc (ARQT) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... [2025-02-26 02:15AM] U.S. FDA Accepts Supplemental New Drug Application for Arcutis' ZORYVE (roflumilast) Cream 0.05% for the Treatment of Children Aged 2 to 5 with Mild to Moderate Atopic Dermatitis [2025-02-26 08:00AM]
06-11-2024	AH		ARQT	Arcutis Biotherapeutics	1,019	-0.33	-0.42	0.00	Arcutis Biotherapeutics GAAP EPS of -$0.33 beats by $0.09, revenue of $44.75M beats by $7.41M [11/6/2024 4:02 PM]	10.41	0.75 (7.82%)	10.13	0.47 (4.87%)	1.76 - 13.17	4,264,673	1,990,000	14,937
Arcutis Biotherapeutics GAAP EPS of -$0.33 beats by $0.09, revenue of $44.75M beats by $7.41M [11/6/2024 4:02 PM]
14-08-2024	AH		ARQT	Arcutis Biotherapeutics, Inc.	1,120	-0.42	-0.48	-1.16	Arcutis Biotherapeutics GAAP EPS of -$0.42 beats by $0.09, revenue of $30.85M beats by $1.77M [8/14/2024 4:16 PM]	8.51	-1.07 (-11.22%)	9.16	-0.42 (-4.38%)	1.76 - 13.17	6,381,812	2,110,000	51,866
Arcutis Biotherapeutics GAAP EPS of -$0.42 beats by $0.09, revenue of $30.85M beats by $1.77M [8/14/2024 4:16 PM]
14-05-2024	AH		ARQT	Arcutis Biotherapeutics, Inc.	759.02	-0.32	-0.60	-1.31	Arcutis Biotherapeutics GAAP EPS of -$0.32 beats by $0.41, revenue of $49.56M [5/14/2024 4:22 PM]	9.15	1.02 (12.55%)	9.38	1.25 (15.38%)	1.76 - 13.17	11,998,331	2,690,000	1,041,791
Arcutis Biotherapeutics GAAP EPS of -$0.32 beats by $0.41, revenue of $49.56M [5/14/2024 4:22 PM] Arcutis Biotherapeutics surges 22% on Q1 beats [5/15/2024 11:45 AM]
27-02-2024	PM		ARQT	Arcutis Biotherapeutics, Inc.	913.62	-0.72	-0.64	-1.18	Arcutis Biotherapeutics GAAP EPS of -$0.72, revenue of $13.5M [2/27/2024 5:52 AM]	10.70	1.01 (10.37%)	10.59	0.90 (9.29%)	1.76 - 17.57	8,527,009	4,930,000	189,394
Arcutis Biotherapeutics Q4 2023 Earnings Preview [2/26/2024 11:19 AM] Arcutis Biotherapeutics GAAP EPS of -$0.72, revenue of $13.5M [2/27/2024 5:52 AM]
03-11-2023	PM		ARQT	Arcutis Biotherapeutics, Inc.	138.72	-0.73	-0.90	-1.89	Arcutis Biotherapeutics GAAP EPS of -$0.73 beats by $0.15, revenue of $38.1M beats by $7.28M [11/3/2023 7:43 AM]	2.44	0.22 (9.91%)	2.48	0.26 (11.71%)	2.13 - 20.11	3,272,826	5,500,000	11,063
Arcutis Biotherapeutics GAAP EPS of -$0.73 beats by $0.15, revenue of $38.1M beats by $7.28M [11/3/2023 7:43 AM]
08-08-2023	AH		ARQT	Arcutis Biotherapeutics, Inc.	603.78	-1.16	-1.22	-1.31	Arcutis Biotherapeutics GAAP EPS of -$1.16 beats by $0.08, revenue of $5.2M beats by $0.58M [8/8/2023 4:15 PM]	9.37	-0.46 (-4.68%)	10.15	0.32 (3.26%)	7.25 - 27.40	787,400	720,000	217
Arcutis Biotherapeutics GAAP EPS of -$1.16 beats by $0.08, revenue of $5.2M beats by $0.58M [8/8/2023 4:15 PM]
09-05-2023	AH	4:00 PM ET (May 9)	ARQT	Arcutis Biotherapeutics, Inc.	893.42	-1.31	-1.29	-1.27	Arcutis Biotherapeutics reports Q1 results [5/9/2023 5:09 PM]	12.04	-2.79 (-18.79%)	14.82	0.0 (0.00%)	10.05 - 27.40	3,927,306	760,000	26,179
Arcutis Biotherapeutics reports Q1 results [5/9/2023 5:09 PM] Arcutis down 20% on Q1 bottom and top line misses [5/10/2023 1:55 PM]
28-02-2023	AH	4:00 PM ET (Feb 28)	ARQT	Arcutis Biotherapeutics, Inc.	966.92	-1.18	-1.37	-1.42	Arcutis Biotherapeutics Q4 results beat estimates [2/28/2023 5:10 PM]	16.70	0.52 (3.21%)	16.18	0.0 (0.00%)	12.81 - 27.40	969,316	720,000	102,921
Arcutis Biotherapeutics Q4 results beat estimates [2/28/2023 5:10 PM]
08-11-2022	AH	4:00 PM ET (Nov 8)	ARQT	Arcutis Biotherapeutics, Inc.	1,080	-1.89	-1.54	-1.14	Arcutis Biotherapeutics GAAP EPS of -$1.89 misses by $0.01, revenue of $0.73M beats by $0.07M [11/8/2022 4:05 PM]	18.62	-0.08 (-0.43%)	18.70	0.0 (0.00%)	13.59 - 27.40	839,860	610,000	9,421
Arcutis Biotherapeutics GAAP EPS of -$1.89 misses by $0.01, revenue of $0.73M beats by $0.07M [11/8/2022 4:05 PM] Arcutis Announces Third Quarter 2022 Financial Results and Provides Business Update [Nov-08-22 04:02PM]
05-05-2022	AH		ARQT	Arcutis Biotherapeutics	1,106	-1.27	-1.42	0.00	Arcutis Biotherapeutics GAAP EPS of -$1.27 beats by $0.22 [5/5/2022 5:48 PM]	19.52	-1.50 (-7.14%)	21.02	0.0 (0.00%)	13.59 - 35.21	320,612	230,000	904
Arcutis Biotherapeutics GAAP EPS of -$1.27 beats by $0.22 [5/5/2022 5:48 PM] Arcutis Announces First Quarter 2022 Financial Results and Provides Business Update [May-05-22 04:01PM] Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [May-05-22 08:00AM]
05-08-2021	AH	4:50 PM ET (Aug 5)	ARQT	Arcutis Biotherapeutics, Inc.	1,147	-0.84	-0.91	0.00	Arcutis Biotherapeutics EPS beats by $0.13 [8/5/2021 5:28 PM]	21.42	-0.41 (-1.88%)	22.00	0.17 (0.78%)	17.51 - 38.49	83,954	170,000	1,565
Arcutis Announces Second Quarter 2021 Financial Results and Provides Business Update [Aug-05-21 04:05PM]
16-02-2021	AH		ARQT	Arcutis Biotherapeutics, Inc.	1,531	-0.79	-0.89	0.00	Arcutis Biotherapeutics EPS beats by $0.06 [2/16/2021 5:00 PM]	35.27	1.58 (4.69%)	33.69	0.0 (0.00%)	17.10 - 40.88	451,634	488,797	144
Arcutis Biotherapeutics EPS beats by $0.06 [2/16/2021 5:00 PM]
11-08-2020	AH		ARQT	Arcutis Biotherapeutics, Inc.	924.10	-0.94	0.00	0.00	Arcutis Biotherapeutics EPS misses by $0.11 [8/11/2020 4:29 PM]	25.02	0.36 (1.46%)	24.66	0.0 (0.00%)	17.10 - 40.88	62,408	102,073	127